Table 3.
Cycle 1 | Cycle 2 | |||
No. | % | No. | % | |
Incomplete monitor dataa | 14 | 5.6 | 37 | 16.0 |
No. of missed tests out of the first 10b | ||||
0 | 120 | 48.2 | 98 | 42.2 |
1–2 | 83 | 33.3 | 77 | 33.2 |
3–4 | 23 | 9.2 | 27 | 11.6 |
5–10 | 22 | 8.8 | 18 | 7.8 |
Unknownc | 1 | 0.4 | 12 | 5.2 |
Estrone-3-glucuronide leveld | ||||
High | 215 | 86.4 | 195 | 84.1 |
No high | 30 | 12.1 | 33 | 14.2 |
Unknowne | 4 | 1.6 | 4 | 1.7 |
Lutenizing hormone level | ||||
Peak | 189 | 75.9 | 180 | 77.6 |
No peak | 49 | 19.7 | 29 | 12.5 |
Unknowne | 11 | 4.4 | 23 | 9.9 |
Clinic visit on peak day among women who reached peak | ||||
Yes | 142 | 75.1 | 148 | 82.2 |
No | 47 | 24.9 | 32 | 17.8 |
No. of missed tests out of first 10b among women with no peakf | ||||
0 | 24 | 40.0 | 15 | 35.7 |
1–2 | 19 | 31.7 | 12 | 28.6 |
3–4 | 5 | 8.3 | 5 | 11.9 |
5–10 | 12 | 20.0 | 10 | 23.8 |
Unknownc | 0 | 10 | ||
Maximum serum progesterone below 5.0 ng/mL among women with no peakf | ||||
<5.0 ng/mL | 21 | 35.0 | 8 | 15.4 |
≥5.0 ng/mL | 39 | 65.0 | 44 | 84.6 |
Most likely reason for not reaching peak among women with no peakf | ||||
Missed test | 10 | 16.7 | 12 | 23.1 |
Monitor data available only before peak | 5 | 8.3 | 12 | 23.1 |
Test stick reading error | 7 | 11.7 | 10 | 19.2 |
Long cycle | 8 | 13.3 | 1 | 1.9 |
Normal cycle length but late luteinizing hormone peak | 2 | 3.3 | 1 | 1.9 |
Early luteinizing hormone surge | 4 | 6.7 | 1 | 1.9 |
Possible low luteinizing hormone surge, serum progesterone ≥5.0 ng/mL | 13 | 21.7 | 11 | 21.2 |
Unlikely ever peaked | 11 | 18.3 | 4 | 7.7 |
Data are incomplete if the woman did not bring her monitor in to have the data downloaded at the end of the testing period. Some of these women brought in their monitors after 10 tests were requested and reached high or peak fertility even though their monitor data were incomplete.
Ten tests were requested of all women (except one woman in cycle 1 whose next period started before 10 tests could be requested).
“Unknown” includes women whose monitor data are incomplete, and therefore it is unknown how many of the first 10 tests were missed.
Only includes women who achieved high fertility prior to the peak (the monitor automatically assigns a value of high fertility the day after the last peak day regardless of the estrone-3-glucuronide level; these women were not counted as high in this analysis).
“Unknown” includes women who did not reach high or peak fertility in the recorded data but who had incomplete monitor data downloaded. It does not include women with complete recorded monitor data who missed tests.
Includes 11 women for cycle 1 and 13 women for cycle 2 who had complete data for the first 10 tests and no observed peak but who had incomplete data for the final 10 requested tests.